The secondary hypothesis is that the experimental group would have demonstrated levels in the following variables compared to the control group: pre-sleep arousal, sleep-related dysfunctional cognitions, maladaptive sleep habits, sleeping patterns, GI symptoms during sleep, inflammation (IL-6, CRP), severity of IBS symptoms and IBS quality of life. The gene discussed is IL6; the disease is irritable bowel syndrome.